NCT02749487

Brief Summary

Neutrophil lymphocyte ratio NLR is an important index that evaluate the inflammatory status . It is a cost effective and readily available , and simply calculated , so that why investigators try to use it as a predictor of short term survival in the critically ill patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 21, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 25, 2016

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2016

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

December 16, 2016

Status Verified

December 1, 2016

Enrollment Period

11 months

First QC Date

April 21, 2016

Last Update Submit

December 15, 2016

Conditions

Critical Care

Keywords

Critical CareNeutrophilsLymphocytes

Outcome Measures

Primary Outcomes (1)

  • short term survival

    one month

Study Arms (2)

cured (c)

Neutrophil Lymphocyte and platelet lymphocyte ratios as Predictors of Outcome in Traumatic Critically ill Patients

Other: Neutrophil Lymphocyte Ratio

Died ( M)

Neutrophil Lymphocyte and platelet lymphocyte ratios as Predictors of Outcome in Traumatic Critically ill Patients

Other: Neutrophil Lymphocyte Ratio

Interventions

Neutrophil Lymphocyte RatioOTHER

Neutrophil:lymphocyte ratio (NLR) is an emerging biomarker that is used to predict mortality and morbidity. The association of this biomarker with systemic illness and its usefulness in risk assessment of critically ill patients has not been fully elucidated.

Died ( M)cured (c)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

80 adult patients who are admitted to critical care unit in Assiut university Hospital

You may qualify if:

  • Critically ill trauma patients

You may not qualify if:

  • auto immune disease endocrine disease renal dysfunction hepatic dysfunction malignancy smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emad Zarief Kamel Said

Asyut, Asyut Governorate, 71111, Egypt

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Anesthesia and critical care Medicine

Study Record Dates

First Submitted

April 21, 2016

First Posted

April 25, 2016

Study Start

June 1, 2015

Primary Completion

May 1, 2016

Study Completion

September 1, 2016

Last Updated

December 16, 2016

Record last verified: 2016-12

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)